Investigate previously unstudied major exposure routes of
pharmaceuticals into the terrestrial and aquatic environment
Investigate factors and processes affecting the fate of
pharmaceuticals in soils, sediments and surface water
Further develop testing and modelling approaches for evaluating the
fate of pharmaceuticals
Develop a scenario-based exposure assessment system for
pharmaceuticals
Explore the use of bioassays for an initial hazard screening and
mode-of-action classification
Evaluate how information on pharmacodynamics and toxicodynamics in
mammals can be used to guide the evaluation of potential sublethal
effects in fish
Modify and refine test methods in order to detect the effects of
long-term, low-level exposure to pharmaceuticals
Investigate whether and to what extent environmentally relevant
concentrations of pharmaceuticals cause effects in the environment
Develop pragmatic approaches for assessing transformation products
Provide recommendations on how to improve current European
environmental risk assessment procedures for pharmaceuticals
